
Malcolm Cribbs
Examiner (ID: 10271, Phone: (571)270-1566 , Office: P/2497 )
| Most Active Art Unit | 2497 |
| Art Unit(s) | 2432, 2497, 2115 |
| Total Applications | 956 |
| Issued Applications | 839 |
| Pending Applications | 36 |
| Abandoned Applications | 93 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18842590
[patent_doc_number] => 20230404994
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => MARKERS OF TISSUE AGING AND USES THEREFOR
[patent_app_type] => utility
[patent_app_number] => 17/860246
[patent_app_country] => US
[patent_app_date] => 2022-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12021
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17860246
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/860246 | MARKERS OF TISSUE AGING AND USES THEREFOR | Jul 7, 2022 | Abandoned |
Array
(
[id] => 19380859
[patent_doc_number] => 20240270729
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-15
[patent_title] => (THI)OXAZOLINE PESTICIDES
[patent_app_type] => utility
[patent_app_number] => 18/569370
[patent_app_country] => US
[patent_app_date] => 2022-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19951
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18569370
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/569370 | (THI)OXAZOLINE PESTICIDES | Jun 14, 2022 | Pending |
Array
(
[id] => 19903045
[patent_doc_number] => 12280029
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-22
[patent_title] => Methods of treatment of inflammation related conditions using pluripotent anti-inflammatory and metabolic modulators
[patent_app_type] => utility
[patent_app_number] => 17/833315
[patent_app_country] => US
[patent_app_date] => 2022-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 2135
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17833315
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/833315 | Methods of treatment of inflammation related conditions using pluripotent anti-inflammatory and metabolic modulators | Jun 5, 2022 | Issued |
Array
(
[id] => 19792153
[patent_doc_number] => 12233076
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-25
[patent_title] => Stable liquid formulations of cyclophosphamide and processes to prepare the same
[patent_app_type] => utility
[patent_app_number] => 17/831926
[patent_app_country] => US
[patent_app_date] => 2022-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11909
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17831926
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/831926 | Stable liquid formulations of cyclophosphamide and processes to prepare the same | Jun 2, 2022 | Issued |
Array
(
[id] => 19403510
[patent_doc_number] => 20240287021
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-29
[patent_title] => QUATERNARY AMMONIUM SALT COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/563807
[patent_app_country] => US
[patent_app_date] => 2022-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17726
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18563807
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/563807 | QUATERNARY AMMONIUM SALT COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF | May 25, 2022 | Pending |
Array
(
[id] => 18604896
[patent_doc_number] => 11746350
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-05
[patent_title] => SiRNA, medical compositions, and methods for treating type ii diabetes using the same
[patent_app_type] => utility
[patent_app_number] => 17/663826
[patent_app_country] => US
[patent_app_date] => 2022-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 13220
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17663826
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/663826 | SiRNA, medical compositions, and methods for treating type ii diabetes using the same | May 16, 2022 | Issued |
Array
(
[id] => 19379254
[patent_doc_number] => 20240269124
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-15
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING NEUROLOGICAL CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 18/561247
[patent_app_country] => US
[patent_app_date] => 2022-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29435
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -168
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18561247
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/561247 | METHODS AND COMPOSITIONS FOR TREATING NEUROLOGICAL CONDITIONS | May 15, 2022 | Pending |
Array
(
[id] => 19730104
[patent_doc_number] => 12208090
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-28
[patent_title] => Compounds for use in treating depression and migraine
[patent_app_type] => utility
[patent_app_number] => 17/742417
[patent_app_country] => US
[patent_app_date] => 2022-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18661
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 233
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17742417
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/742417 | Compounds for use in treating depression and migraine | May 11, 2022 | Issued |
Array
(
[id] => 19331206
[patent_doc_number] => 20240245636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-25
[patent_title] => COMPOSITION FOR INCREASING MUSCLE MASS
[patent_app_type] => utility
[patent_app_number] => 18/289935
[patent_app_country] => US
[patent_app_date] => 2022-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7866
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18289935
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/289935 | COMPOSITION FOR INCREASING MUSCLE MASS | May 9, 2022 | Pending |
Array
(
[id] => 17790309
[patent_doc_number] => 20220249400
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => SOLUBILIZATE WITH CURCUMIN AND BOSWELLIA AND XANTHOHUMOL
[patent_app_type] => utility
[patent_app_number] => 17/730356
[patent_app_country] => US
[patent_app_date] => 2022-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7208
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17730356
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/730356 | SOLUBILIZATE WITH CURCUMIN AND BOSWELLIA AND XANTHOHUMOL | Apr 26, 2022 | Abandoned |
Array
(
[id] => 18064395
[patent_doc_number] => 20220395482
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-15
[patent_title] => GLYCOGEN OR POLYSACCHARIDE STORAGE DISEASE TREATMENT METHOD
[patent_app_type] => utility
[patent_app_number] => 17/726934
[patent_app_country] => US
[patent_app_date] => 2022-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18753
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17726934
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/726934 | GLYCOGEN OR POLYSACCHARIDE STORAGE DISEASE TREATMENT METHOD | Apr 21, 2022 | Abandoned |
Array
(
[id] => 17774885
[patent_doc_number] => 20220241234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => METHODS OF TREATING MIXED DYSLIPIDEMIA
[patent_app_type] => utility
[patent_app_number] => 17/725357
[patent_app_country] => US
[patent_app_date] => 2022-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23811
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17725357
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/725357 | METHODS OF TREATING MIXED DYSLIPIDEMIA | Apr 19, 2022 | Abandoned |
Array
(
[id] => 17774943
[patent_doc_number] => 20220241292
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM
[patent_app_type] => utility
[patent_app_number] => 17/723771
[patent_app_country] => US
[patent_app_date] => 2022-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24863
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17723771
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/723771 | Pharmaceutical compositions comprising meloxicam | Apr 18, 2022 | Issued |
Array
(
[id] => 19318259
[patent_doc_number] => 20240239801
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-18
[patent_title] => PYRIMIDO[5,4,D]PYRIMIDINE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/287524
[patent_app_country] => US
[patent_app_date] => 2022-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48879
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18287524
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/287524 | PYRIMIDO[5,4,D]PYRIMIDINE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES THEREOF | Apr 18, 2022 | Pending |
Array
(
[id] => 17759885
[patent_doc_number] => 20220233497
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => CANNABINOID DERIVATIVES AND METHODS FOR THEIR PREPARATION
[patent_app_type] => utility
[patent_app_number] => 17/723935
[patent_app_country] => US
[patent_app_date] => 2022-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15609
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 692
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17723935
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/723935 | Cannabinoid derivatives and methods for their preparation | Apr 18, 2022 | Issued |
Array
(
[id] => 19263568
[patent_doc_number] => 20240207265
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => TREATMENT OF CNS DISEASES WITH sGC STIMULATORS
[patent_app_type] => utility
[patent_app_number] => 18/287616
[patent_app_country] => US
[patent_app_date] => 2022-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30785
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18287616
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/287616 | TREATMENT OF CNS DISEASES WITH sGC STIMULATORS | Apr 18, 2022 | Pending |
Array
(
[id] => 19279858
[patent_doc_number] => 20240216330
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-04
[patent_title] => COMBINATION TREATMENT METHODS OF MULTIPLE SCLEROSIS
[patent_app_type] => utility
[patent_app_number] => 18/285123
[patent_app_country] => US
[patent_app_date] => 2022-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10098
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -47
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18285123
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/285123 | COMBINATION TREATMENT METHODS OF MULTIPLE SCLEROSIS | Mar 31, 2022 | Pending |
Array
(
[id] => 18978786
[patent_doc_number] => 11903940
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-20
[patent_title] => Methods of treating disease with levoketoconazole
[patent_app_type] => utility
[patent_app_number] => 17/655632
[patent_app_country] => US
[patent_app_date] => 2022-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10540
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17655632
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/655632 | Methods of treating disease with levoketoconazole | Mar 20, 2022 | Issued |
Array
(
[id] => 17702802
[patent_doc_number] => 20220202808
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => Compositions For Affecting Weight Loss
[patent_app_type] => utility
[patent_app_number] => 17/699600
[patent_app_country] => US
[patent_app_date] => 2022-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14160
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17699600
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/699600 | Compositions For Affecting Weight Loss | Mar 20, 2022 | Abandoned |
Array
(
[id] => 19650007
[patent_doc_number] => 12171767
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-24
[patent_title] => Uses of DPP IV inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/681997
[patent_app_country] => US
[patent_app_date] => 2022-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8944
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17681997
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/681997 | Uses of DPP IV inhibitors | Feb 27, 2022 | Issued |